US Stock MarketDetailed Quotes

Bone Biologics (BBLG)

Watchlist
  • 1.360
  • +0.010+0.74%
Close Apr 24 16:00 ET
  • 1.330
  • -0.030-2.21%
Post 20:01 ET
2.44MMarket Cap-0.51P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bone Biologics (BBLG) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
60.42%5.33M
60.42%5.33M
69.61%6.05M
184.75%6.64M
-14.91%2.75M
9.86%3.33M
9.86%3.33M
-19.90%3.57M
-66.72%2.33M
-47.84%3.23M
-Cash and cash equivalents
60.42%5.33M
60.42%5.33M
69.61%6.05M
184.75%6.64M
-14.91%2.75M
9.86%3.33M
9.86%3.33M
-19.90%3.57M
-66.72%2.33M
-47.84%3.23M
Receivables
--9.9K
--9.9K
----
----
----
--0
--0
----
----
----
-Accrued interest receivable
--9.9K
--9.9K
----
----
----
--0
--0
----
----
----
Prepaid assets
-15.72%451.92K
-15.72%451.92K
-39.58%301.72K
-58.00%361.75K
-32.10%415.51K
-24.60%536.24K
-24.60%536.24K
-4.65%499.39K
40.01%861.4K
2.77%611.94K
Total current assets
50.11%5.8M
50.11%5.8M
56.20%6.35M
119.27%7M
-17.65%3.16M
3.31%3.86M
3.31%3.86M
-18.30%4.07M
-58.11%3.19M
-43.40%3.84M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
50.11%5.8M
50.11%5.8M
56.20%6.35M
119.27%7M
-17.65%3.16M
3.31%3.86M
3.31%3.86M
-18.30%4.07M
-58.11%3.19M
-43.40%3.84M
Liabilities
Current liabilities
Payables
12.02%417.88K
12.02%417.88K
75.25%333.08K
74.12%403.73K
69.54%247.84K
3.43%373.04K
3.43%373.04K
--190.06K
--231.87K
--146.19K
-accounts payable
12.02%417.88K
12.02%417.88K
75.25%333.08K
74.12%403.73K
69.54%247.84K
3.43%373.04K
3.43%373.04K
--190.06K
--231.87K
--146.19K
Current accrued expenses
----
----
----
----
----
--0
--0
--0
--0
----
Current deferred liabilities
----
----
----
----
----
--0
--0
--65.72K
--44.98K
----
Other current liabilities
-84.95%703
-84.95%703
-93.19%1.2K
-68.48%2.41K
-82.02%3.32K
-91.62%4.67K
-91.62%4.67K
-78.10%17.63K
-96.83%7.66K
-98.94%18.44K
Current liabilities
10.82%418.59K
10.82%418.59K
22.27%334.28K
42.75%406.14K
52.56%251.16K
-54.57%377.71K
-54.57%377.71K
-76.89%273.4K
-85.26%284.51K
-95.90%164.63K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
10.82%418.59K
10.82%418.59K
22.27%334.28K
42.75%406.14K
52.56%251.16K
-54.57%377.71K
-54.57%377.71K
-76.89%273.4K
-85.26%284.51K
-95.90%164.63K
Shareholders'equity
Share capital
264.84%1.8K
264.84%1.8K
-14.36%1.8K
28.14%1.69K
221.85%3.27K
-7.87%492
-7.87%492
-33.14%2.1K
-58.05%1.32K
-93.92%1.02K
-common stock
264.84%1.8K
264.84%1.8K
-14.36%1.8K
28.14%1.69K
221.85%3.27K
-7.87%492
-7.87%492
-33.14%2.1K
-58.05%1.32K
-93.92%1.02K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-3.66%-88.13M
-3.66%-88.13M
-4.73%-87.45M
-5.11%-86.78M
-5.21%-86.04M
-5.08%-85.02M
-5.08%-85.02M
-5.22%-83.5M
-6.61%-82.56M
-8.07%-81.77M
Paid-in capital
5.65%93.51M
5.65%93.51M
7.07%93.46M
9.25%93.37M
4.09%88.95M
5.60%88.5M
5.60%88.5M
4.98%87.29M
2.81%85.47M
8.96%85.45M
Total stockholders'equity
54.37%5.38M
54.37%5.38M
58.65%6.02M
126.75%6.6M
-20.79%2.91M
19.86%3.48M
19.86%3.48M
-0.02%3.79M
-48.90%2.91M
32.55%3.67M
Total equity
54.37%5.38M
54.37%5.38M
58.65%6.02M
126.75%6.6M
-20.79%2.91M
19.86%3.48M
19.86%3.48M
-0.02%3.79M
-48.90%2.91M
32.55%3.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 60.42%5.33M60.42%5.33M69.61%6.05M184.75%6.64M-14.91%2.75M9.86%3.33M9.86%3.33M-19.90%3.57M-66.72%2.33M-47.84%3.23M
-Cash and cash equivalents 60.42%5.33M60.42%5.33M69.61%6.05M184.75%6.64M-14.91%2.75M9.86%3.33M9.86%3.33M-19.90%3.57M-66.72%2.33M-47.84%3.23M
Receivables --9.9K--9.9K--------------0--0------------
-Accrued interest receivable --9.9K--9.9K--------------0--0------------
Prepaid assets -15.72%451.92K-15.72%451.92K-39.58%301.72K-58.00%361.75K-32.10%415.51K-24.60%536.24K-24.60%536.24K-4.65%499.39K40.01%861.4K2.77%611.94K
Total current assets 50.11%5.8M50.11%5.8M56.20%6.35M119.27%7M-17.65%3.16M3.31%3.86M3.31%3.86M-18.30%4.07M-58.11%3.19M-43.40%3.84M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 50.11%5.8M50.11%5.8M56.20%6.35M119.27%7M-17.65%3.16M3.31%3.86M3.31%3.86M-18.30%4.07M-58.11%3.19M-43.40%3.84M
Liabilities
Current liabilities
Payables 12.02%417.88K12.02%417.88K75.25%333.08K74.12%403.73K69.54%247.84K3.43%373.04K3.43%373.04K--190.06K--231.87K--146.19K
-accounts payable 12.02%417.88K12.02%417.88K75.25%333.08K74.12%403.73K69.54%247.84K3.43%373.04K3.43%373.04K--190.06K--231.87K--146.19K
Current accrued expenses ----------------------0--0--0--0----
Current deferred liabilities ----------------------0--0--65.72K--44.98K----
Other current liabilities -84.95%703-84.95%703-93.19%1.2K-68.48%2.41K-82.02%3.32K-91.62%4.67K-91.62%4.67K-78.10%17.63K-96.83%7.66K-98.94%18.44K
Current liabilities 10.82%418.59K10.82%418.59K22.27%334.28K42.75%406.14K52.56%251.16K-54.57%377.71K-54.57%377.71K-76.89%273.4K-85.26%284.51K-95.90%164.63K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 10.82%418.59K10.82%418.59K22.27%334.28K42.75%406.14K52.56%251.16K-54.57%377.71K-54.57%377.71K-76.89%273.4K-85.26%284.51K-95.90%164.63K
Shareholders'equity
Share capital 264.84%1.8K264.84%1.8K-14.36%1.8K28.14%1.69K221.85%3.27K-7.87%492-7.87%492-33.14%2.1K-58.05%1.32K-93.92%1.02K
-common stock 264.84%1.8K264.84%1.8K-14.36%1.8K28.14%1.69K221.85%3.27K-7.87%492-7.87%492-33.14%2.1K-58.05%1.32K-93.92%1.02K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -3.66%-88.13M-3.66%-88.13M-4.73%-87.45M-5.11%-86.78M-5.21%-86.04M-5.08%-85.02M-5.08%-85.02M-5.22%-83.5M-6.61%-82.56M-8.07%-81.77M
Paid-in capital 5.65%93.51M5.65%93.51M7.07%93.46M9.25%93.37M4.09%88.95M5.60%88.5M5.60%88.5M4.98%87.29M2.81%85.47M8.96%85.45M
Total stockholders'equity 54.37%5.38M54.37%5.38M58.65%6.02M126.75%6.6M-20.79%2.91M19.86%3.48M19.86%3.48M-0.02%3.79M-48.90%2.91M32.55%3.67M
Total equity 54.37%5.38M54.37%5.38M58.65%6.02M126.75%6.6M-20.79%2.91M19.86%3.48M19.86%3.48M-0.02%3.79M-48.90%2.91M32.55%3.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -